M&A / Deals Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Pharmaceutical TechnologyDaiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology.M&A / DealsRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaceutical Technology Daiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology. M&A / DealsRead full story Post navigation Previous: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC directorNext: Trump names Erica Schwartz to fill leadership void at CDC Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
